RT Journal Article
SR Electronic
A1 O'Loughlin, Taryn
T1 Pioglitazone Exhibits a Beneficial Effect on CIMT in Patients with Type 2 Diabetes
JF MD Conference Express
YR 2006
FD SAGE Publications
VO 6
IS 5
SP 12
OP 13
DO 10.1177/155989770600600503
UL http://mdc.sagepub.com/content/6/5/12.abstract
AB Patients with type 2 diabetes are at greater risk for cardiovascular events, and thiazolidinediones, approved for the management of type 2 diabetes, have demonstrated an atheroprotective effect in animal models of atheroscleroisis. The CHICAGO study sought to further elucidate the potential protective effect of the thiazolidinedione pioglitazone in patients with type 2 diabetes.